Bonsai Biotherapeutics AB
559523-4435ActiveBiotherapeutics operations assumed following major corporate merger completion.
Oversikt
- 10–19
- Ansatte
- Ukjent
- Omsetning
- 2025
- Grunnlagt
Beskrivelse
The organization detailed here represents the operational successor to Toleranzia AB following a formal merger with Flerie AB. This complex corporate restructuring, finalized in August 2025, involved the dissolution of Toleranzia and the transfer of all its assets and liabilities. These undertakings...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559523443501
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrMoligo Technologies AB
4 ansatteMoligo provides ultrapure, long single-stranded DNA synthesis services at scale.
Theralia AB
0 ansattePioneering biotech revolutionizing drug delivery via TOUCAN technology.
Cell4Cure AB
Pioneering antigen-specific immune tolerance therapies using engineered dendritic cells.
Disruptive Pharma AB (publ)
5–9 ansatteSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
LIDDS AB
1–4 ansatteSwedish drug delivery company utilizing proprietary NanoZolid technology platform.
Utforsk mer
Spørsmål om Bonsai Biotherapeutics AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo